PUBPOL 5113

PUBPOL 5113

Course information provided by the Courses of Study 2024-2025.

This course provides an overview of the key management issues facing the pharmaceutical and biotechnology industries. The emphasis is on the United States because it is the largest and most profitable market, but we will briefly cover issues affecting global markets.

When Offered Fall.

Permission Note Enrollment limited to: Sloan Executive Master of Health Administration (EMHA) students.

Outcomes
  • Through this course, students will learn to analyze how decisions made throughout drug testing and development impact a drug's performance over its lifecycle.
  • Describe how firms set prices and negotiate with health insurers.
  • Anticipate the pros and cons of a merger, acquisition, or alliance opportunity.
  • Deconstruct and critique drug marketing strategies.

View Enrollment Information

Syllabi:
  •   Seven Week - First. 

  • 1 Credit Graded

  • 12990 PUBPOL 5113   LEC 001

    • TR Online Meeting
    • Aug 26 - Sep 28, 2024
    • Nicholson, S

  • Instruction Mode: Distance Learning-Synchronous